7. Decrease in COVID-19 cases from Ivermectin
On the other hand, some reports say that Ivermectin is no longer a COVID-19 drug in India. However, different data were disclosed The Desert Review berjudul, Ivermectin obliterates 97 percent of Delhi cases.
The article above states that a 97 percent decrease in COVID-19 cases occurred after taking Ivermectin.
“Precisely the data from The Desert Review revealed that the use of Ivermectin reduced 97 percent of the spike in COVID-19 in India,” said Chairman of the Central Java HKTI Nur Faisah in a written statement received Health Liputan6.com, Monday (14/6/2021).
Nur said from the data, there is an area called Tamil Nadhu, an area that does not use Ivermectin, the number of which has actually increased exposure to COVID-19 from 10,986 to 36,184 or a threefold increase.
“It is precisely Tamil Nadhu’s refusal to use Ivermectin, to their own detriment,” he added.
Not only did the COVID-19 cases in Tamil Nadhu increase the most in India, but also deaths jumped sharply from 48 cases on April 20, 2021, to 474 on May 27, a 10-fold jump.
Meanwhile, at the same time the deaths in Delhi fell from 277 to 117 cases. Areas in India that use Ivermectin and have decreased cases include:
Delhi: 97 percent (28,395 down to 956)
Uttar Pradesh: 95 percent (37,944 down to 2,014)
Goa: 85 percent (4,195 down to 645)
Karnataka: 60 percent (50,112 down to 20,378)
Uttarakhan: 87 percent (9,642 down to 1,226)
– .